Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Asada, Yukinori  [Clear All Filters]
2024
Mochizuki M, Shibuya-Takahashi R, Kanno S-I, Adachi S, Fujimori H, Nakazato A, Fujii K, Morita S, Saijoh S, Yamazaki T, et al. CD271 mRNA/hnRNPA2B1 complex promotes proliferation and stemness in oral and head and neck squamous cell carcinoma. Cancer Sci. 2024.
2022
Nakazato A, Mochizuki M, Shibuya-Takahashi R, Fujimori H, Fujii K, Saijoh S, Morita S, Yamazaki T, Imai T, Sato I, et al. RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer. Sci Rep. 2022;12(1):17751.
2021
Saijoh S, Nakamura-Shima M, Shibuya-Takahashi R, Ito R, Sugawara A, Yamazaki T, Imai T, Asada Y, Matsuura K, Iwai W, et al. Discovery of a chemical compound that suppresses expression of BEX2, a dormant cancer stem cell-related protein. Biochem Biophys Res Commun. 2021;537:132-139.
2020
Morita S, Mochizuki M, Shibuya-Takahashi R, Nakamura-Shima M, Yamazaki T, Imai T, Asada Y, Matsuura K, Kawamura S, Yamaguchi K, et al. Establishment of a Monoclonal Antibody That Recognizes Cysteine-Rich Domain 1 of Human CD271. Monoclon Antib Immunodiagn Immunother. 2020;39(1):6-11.
2019
Morita S, Mochizuki M, Wada K, Shibuya R, Nakamura M, Yamaguchi K, Yamazaki T, Imai T, Asada Y, Matsuura K, et al. Humanized anti-CD271 monoclonal antibody exerts an anti-tumor effect by depleting cancer stem cells. Cancer Lett. 2019.